Market Tracker

02/22 4:42pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

2.60
Delayed Data
As of Feb 22
 -0.10 / -3.70%
Today’s Change
2.35
Today|||52-Week Range
5.48
+6.12%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close2.70
Today’s open2.70
Day’s range2.60 - 2.75
Volume70,400
Average volume (3 months)266,362
Market cap$148.1M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-181.34%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.27

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.45-6.44%
XENEXenon Pharmaceutical...-0.05-0.61%
SMMTSummit Therapeutics ...+0.04+0.34%
VTLVital Therapies Inc0.000.00%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts